<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>jmedicalcasereports</PublisherName>
<JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Volume 2; Issue 1, (Jan-Jun,2021)</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>Cancer Case Reports</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Cancer Case Reports</ArticleType>
<ArticleTitle>Primary Occult Breast Cancer in A Male Patient: A Case Report and Brief Overview of Literature</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>1</FirstPage>
<LastPage>7</LastPage>
<AuthorList>
<Author>
<FirstName>Luis E. Fregoso</FirstName>
<LastName>Arteaga</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Benjamin Zavala</FirstName>
<LastName>Retes</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Fatima Rincon</FirstName>
<LastName>Cabada</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Michael P.</FirstName>
<LastName>White</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>Breast cancer is the most common female cancer, nevertheless it represents a rare entity in male patients; the presentation of breast cancer as a primary occult cancer in male patients is such a rare pathology that only case reports have been described. We present a 48 year old man who developed and axillary mass which resulted to be metastatic breast cancer, he was treated in the same fashion as female patients are treated.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Male Breast Cancer,Primary Occult Cancer,Breast Cancer</Keywords>
<URLs>
<Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=15143&title=Primary Occult Breast Cancer in A Male Patient: A Case Report and Brief Overview of Literature</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>American College of Radiology. ACR BI-RADS®-Mammography: Breast Imaging Reporting and Data System, Breast Imaging Atlas, vol 4. ACR, Preston, 2003.
Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010; 28: 232–239.
Bell DW. Our changing view of the genomic landscape of cancer. J Pathol 2010; 220: 231–243.
Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61–70.
Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL. Racial disparities in treatment and survival of male breast cancer. J Clin Oncol 2007; 25: 1089-1098
Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006; 367: 595–604.
Globocan. Intrnational angency for Research on Cancer. 2018; Http: //iar.fr/
Halsted WSI. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 46: 1-19.
Hong JH, Ha KS, Jung YH, Won HS, An HJ, Lee GJ, Kang D, Park JC, Park S, Byun JH, Suh YJ. Clinical features of male breast cancer: experiences from seven institutions over 20 years. Cancer Res Treat 2016; 48: 1389–1398.
Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 2004; 22: 4691-4699
Metin Yalaza, Ayd?n ?nan, Mikdat Bozer. Male Breast Cancer. J Breast Health 2016; 12: 1-8
Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 2007; 109: 1471–1477.
National Cancer Institute, Surveillance, Epidemiology, and End Results Program SEER Cancer Statistics Review, 1975-2011.
Patten DK, Sharifi LK, Fazel M. New approaches in the management of male breast cancer. Clin Breast Cancer 2013; 13: 309–314
Ruixin Xu, Jianbin Li, Yingjie Zhang, Hongbiao Jing, Youzhe Zhu. Male occult breast cancer with axillary lymph node metastasis as the first manifestation. Medicine 2017; 96: 51.
Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53: 538-549.
Sousa B, Moser E, Cardoso F. An update on male breast cancer and future directions.
Wang X, Zhao Y, Cao X. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases. Breast J 2010; 16: 32–37.
Yan-Hui Zhu, Meng-Yao Luo, Zhong Ji, Ju-Feng Guo. Diagnoses and Therapy of Occult Breast Cancer: A Systematic Review. Zhu et al., J Mol Biomark Diagn 2016, S: 2.</References>
</References>
</Journal>
</Article>
</ArticleSet>